Article Details
Retrieved on: 2021-03-09 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The patents are related to the Symbicort Turbohaler, one of AstraZeneca's most popular products. The court also dismissed Mylan's argument that the ...
Article found on: www.lifesciencesipreview.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here